Diebold Nixdorf, Incorporated DBD
Nov 12, 2026, 10:14 AM EST
- YTD
- -15.31%
- 1 year
- -11.79%
DBD free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
239,000,000 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 239,000,000 | 130,200,000 | 119.67% |
| FY 2024 | 2024-12-31 | 108,800,000 | Not available | Not available |
| FY 2022 | 2022-12-31 | -435,000,000 | -508,700,000 | -690.23% |
| FY 2021 | 2021-12-31 | 73,700,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-10-31T06:00:33.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.